3

OWNERSHIP DOCUMENT

Company: BRAINSTORM CELL THERAPEUTICS INC.
Filed: June 1, 2020
Period of Report: June 1, 2020
Accession Number: 0001104659-20-068499

View Document ↗ View on SEC.gov ↗